| UniProt ID | LRIF1_HUMAN | |
|---|---|---|
| UniProt AC | Q5T3J3 | |
| Protein Name | Ligand-dependent nuclear receptor-interacting factor 1 | |
| Gene Name | LRIF1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 769 | |
| Subcellular Localization | Nucleus matrix . | |
| Protein Description | Represses the ligand-induced transcriptional activity of retinoic acid receptor alpha (RARA). This repression may occur through direct recruitment of histone deacetylases.. | |
| Protein Sequence | MSNNLRRVFLKPAEENSGNASRCVSGCMYQVVQTIGSDGKNLLQLLPIPKSSGNLIPLVQSSVMSDALKGNTGKPVQVTFQTQISSSSTSASVQLPIFQPASSSNYFLTRTVDTSEKGRVTSVGTGNFSSSVSKVQSHGVKIDGLTMQTFAVPPSTQKDSSFIVVNTQSLPVTVKSPVLPSGHHLQIPAHAEVKSVPASSLPPSVQQKILATATTSTSGMVEASQMPTVIYVSPVNTVKNVVTKNFQNIYPKPVTEIAKPVILNTTQIPKNVATETQLKGGQHSQAAPVKWIFQDNLQPFTPSLVPVKSSNNVASKILKTFVDRKNLGDNTINMPPLSTIDPSGTRSKNMPIKDNALVMFNGKVYLLAKKGTDVLPSQIDQQNSVSPDTPVRKDTLQTVSSSPVTEISREVVNIVLAKSKSSQMETKSLSNTQLASMANLRAEKNKVEKPSPSTTNPHMNQSSNYLKQSKTLFTNPIFPVGFSTGHNAPRKVTAVIYARKGSVLQSIEKISSSVDATTVTSQQCVFRDQEPKIHNEMASTSDKGAQGRNDKKDSQGRSNKALHLKSDAEFKKIFGLTKDLRVCLTRIPDHLTSGEGFDSFSSLVKSGTYKETEFMVKEGERKQQNFDKKRKAKTNKKMDHIKKRKTENAYNAIINGEANVTGSQLLSSILPTSDVSQHNILTSHSKTRQEKRTEMEYYTHEKQEKGTLNSNAAYEQSHFFNKNYTEDIFPVTPPELEETIRDEKIRRLKQVLREKEAALEEMRKKMHQK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSNNLRRVF ------CCCCCCEEE | 34.13 | 29978859 | |
| 7 | Ubiquitination | -MSNNLRRVFLKPAE -CCCCCCEEECCCCC | 27.06 | 22817900 | |
| 11 | Sumoylation | NLRRVFLKPAEENSG CCCEEECCCCCCCCC | 30.62 | - | |
| 11 | Acetylation | NLRRVFLKPAEENSG CCCEEECCCCCCCCC | 30.62 | 26051181 | |
| 11 | Sumoylation | NLRRVFLKPAEENSG CCCEEECCCCCCCCC | 30.62 | - | |
| 11 | Ubiquitination | NLRRVFLKPAEENSG CCCEEECCCCCCCCC | 30.62 | 21906983 | |
| 11 (in isoform 1) | Ubiquitination | - | 30.62 | 21906983 | |
| 17 | Phosphorylation | LKPAEENSGNASRCV CCCCCCCCCCHHHHH | 36.38 | 25262027 | |
| 21 | Phosphorylation | EENSGNASRCVSGCM CCCCCCHHHHHHHHH | 30.16 | 25262027 | |
| 29 | Ubiquitination | RCVSGCMYQVVQTIG HHHHHHHHHHHHHHC | 11.39 | 29967540 | |
| 50 | Ubiquitination | LQLLPIPKSSGNLIP HHHEECCCCCCCCHH | 58.95 | - | |
| 51 | O-linked_Glycosylation | QLLPIPKSSGNLIPL HHEECCCCCCCCHHH | 37.82 | 30059200 | |
| 52 | O-linked_Glycosylation | LLPIPKSSGNLIPLV HEECCCCCCCCHHHH | 37.51 | 30059200 | |
| 65 | O-linked_Glycosylation | LVQSSVMSDALKGNT HHHHHHHHHHHCCCC | 19.99 | 30059200 | |
| 65 | Phosphorylation | LVQSSVMSDALKGNT HHHHHHHHHHHCCCC | 19.99 | 18669648 | |
| 69 | Ubiquitination | SVMSDALKGNTGKPV HHHHHHHCCCCCCCE | 52.41 | 21963094 | |
| 69 (in isoform 2) | Ubiquitination | - | 52.41 | 21906983 | |
| 72 | O-linked_Glycosylation | SDALKGNTGKPVQVT HHHHCCCCCCCEEEE | 56.08 | 30059200 | |
| 74 | Ubiquitination | ALKGNTGKPVQVTFQ HHCCCCCCCEEEEEE | 39.72 | 22817900 | |
| 85 | O-linked_Glycosylation | VTFQTQISSSSTSAS EEEEEEECCCCCCCE | 17.85 | 30059200 | |
| 89 | O-linked_Glycosylation | TQISSSSTSASVQLP EEECCCCCCCEEEEE | 30.20 | 30059200 | |
| 90 | O-linked_Glycosylation | QISSSSTSASVQLPI EECCCCCCCEEEEEE | 22.09 | 30059200 | |
| 107 | Ubiquitination | PASSSNYFLTRTVDT CCCCCCEEEEEEEEC | 7.03 | 22505724 | |
| 122 | Phosphorylation | SEKGRVTSVGTGNFS CCCCCEEEEECCCCC | 18.72 | - | |
| 134 | Ubiquitination | NFSSSVSKVQSHGVK CCCCCCHHHHHCCEE | 41.98 | 22505724 | |
| 160 | Phosphorylation | PPSTQKDSSFIVVNT CCCCCCCCCEEEEEC | 33.90 | 27690223 | |
| 161 | Phosphorylation | PSTQKDSSFIVVNTQ CCCCCCCCEEEEECC | 29.17 | 27690223 | |
| 166 | Ubiquitination | DSSFIVVNTQSLPVT CCCEEEEECCCCCEE | 22.85 | 29967540 | |
| 175 | Ubiquitination | QSLPVTVKSPVLPSG CCCCEEEECCCCCCC | 39.41 | - | |
| 176 | Phosphorylation | SLPVTVKSPVLPSGH CCCEEEECCCCCCCC | 18.86 | 25849741 | |
| 186 | Ubiquitination | LPSGHHLQIPAHAEV CCCCCCCCCCCCEEE | 34.95 | 29967540 | |
| 194 | Ubiquitination | IPAHAEVKSVPASSL CCCCEEECCCCHHHC | 36.92 | 29967540 | |
| 208 | Ubiquitination | LPPSVQQKILATATT CCHHHHHHHHHHEEC | 23.69 | 29967540 | |
| 214 | Phosphorylation | QKILATATTSTSGMV HHHHHHEECCCCCCC | 19.54 | - | |
| 215 | Phosphorylation | KILATATTSTSGMVE HHHHHEECCCCCCCC | 27.78 | - | |
| 219 | Ubiquitination | TATTSTSGMVEASQM HEECCCCCCCCHHHC | 25.01 | 30230243 | |
| 244 | Sumoylation | TVKNVVTKNFQNIYP CHHHHHCCCCCCCCC | 44.12 | - | |
| 244 | Sumoylation | TVKNVVTKNFQNIYP CHHHHHCCCCCCCCC | 44.12 | - | |
| 244 | Ubiquitination | TVKNVVTKNFQNIYP CHHHHHCCCCCCCCC | 44.12 | 29967540 | |
| 250 | Phosphorylation | TKNFQNIYPKPVTEI CCCCCCCCCCCHHHC | 16.86 | 30622161 | |
| 252 | Ubiquitination | NFQNIYPKPVTEIAK CCCCCCCCCHHHCCC | 34.84 | 21963094 | |
| 255 | Phosphorylation | NIYPKPVTEIAKPVI CCCCCCHHHCCCCEE | 30.15 | 30622161 | |
| 259 | Sumoylation | KPVTEIAKPVILNTT CCHHHCCCCEEECCC | 45.54 | - | |
| 259 | Sumoylation | KPVTEIAKPVILNTT CCHHHCCCCEEECCC | 45.54 | 28112733 | |
| 259 | Ubiquitination | KPVTEIAKPVILNTT CCHHHCCCCEEECCC | 45.54 | 29967540 | |
| 263 | Ubiquitination | EIAKPVILNTTQIPK HCCCCEEECCCCCCC | 4.79 | 22505724 | |
| 270 | Sumoylation | LNTTQIPKNVATETQ ECCCCCCCCCCCCCC | 66.73 | - | |
| 270 | Sumoylation | LNTTQIPKNVATETQ ECCCCCCCCCCCCCC | 66.73 | - | |
| 279 | Sumoylation | VATETQLKGGQHSQA CCCCCCCCCCCCCCC | 51.70 | - | |
| 279 | Methylation | VATETQLKGGQHSQA CCCCCCCCCCCCCCC | 51.70 | 42341213 | |
| 279 | Sumoylation | VATETQLKGGQHSQA CCCCCCCCCCCCCCC | 51.70 | 28112733 | |
| 279 | Ubiquitination | VATETQLKGGQHSQA CCCCCCCCCCCCCCC | 51.70 | 21906983 | |
| 279 (in isoform 1) | Ubiquitination | - | 51.70 | 21906983 | |
| 281 | Ubiquitination | TETQLKGGQHSQAAP CCCCCCCCCCCCCCC | 22.05 | 21963094 | |
| 290 | Sumoylation | HSQAAPVKWIFQDNL CCCCCCCEEEECCCC | 33.25 | - | |
| 290 | Acetylation | HSQAAPVKWIFQDNL CCCCCCCEEEECCCC | 33.25 | 19608861 | |
| 290 | Sumoylation | HSQAAPVKWIFQDNL CCCCCCCEEEECCCC | 33.25 | 19608861 | |
| 290 | Ubiquitination | HSQAAPVKWIFQDNL CCCCCCCEEEECCCC | 33.25 | 29967540 | |
| 298 | Ubiquitination | WIFQDNLQPFTPSLV EEECCCCCCCCCCCC | 37.00 | 22505724 | |
| 308 | Sumoylation | TPSLVPVKSSNNVAS CCCCCCCCCCCCHHH | 41.94 | - | |
| 308 | Sumoylation | TPSLVPVKSSNNVAS CCCCCCCCCCCCHHH | 41.94 | - | |
| 308 | Ubiquitination | TPSLVPVKSSNNVAS CCCCCCCCCCCCHHH | 41.94 | 21963094 | |
| 316 | Sumoylation | SSNNVASKILKTFVD CCCCHHHHHHHHHHH | 42.17 | - | |
| 316 | Acetylation | SSNNVASKILKTFVD CCCCHHHHHHHHHHH | 42.17 | 25953088 | |
| 316 | Sumoylation | SSNNVASKILKTFVD CCCCHHHHHHHHHHH | 42.17 | - | |
| 316 | Ubiquitination | SSNNVASKILKTFVD CCCCHHHHHHHHHHH | 42.17 | 29967540 | |
| 319 | Sumoylation | NVASKILKTFVDRKN CHHHHHHHHHHHHCC | 43.31 | - | |
| 319 | Sumoylation | NVASKILKTFVDRKN CHHHHHHHHHHHHCC | 43.31 | - | |
| 319 | Ubiquitination | NVASKILKTFVDRKN CHHHHHHHHHHHHCC | 43.31 | 29967540 | |
| 325 | Trimethylation | LKTFVDRKNLGDNTI HHHHHHHCCCCCCCC | 52.65 | - | |
| 325 | Methylation | LKTFVDRKNLGDNTI HHHHHHHCCCCCCCC | 52.65 | - | |
| 325 | Ubiquitination | LKTFVDRKNLGDNTI HHHHHHHCCCCCCCC | 52.65 | 22505724 | |
| 342 | Ubiquitination | PPLSTIDPSGTRSKN CCCCCCCCCCCCCCC | 30.70 | 21963094 | |
| 343 | Ubiquitination | PLSTIDPSGTRSKNM CCCCCCCCCCCCCCC | 49.39 | 22817900 | |
| 348 | Ubiquitination | DPSGTRSKNMPIKDN CCCCCCCCCCCCCCC | 54.71 | 29967540 | |
| 353 | Sumoylation | RSKNMPIKDNALVMF CCCCCCCCCCEEEEE | 38.77 | - | |
| 353 | Sumoylation | RSKNMPIKDNALVMF CCCCCCCCCCEEEEE | 38.77 | - | |
| 353 | Ubiquitination | RSKNMPIKDNALVMF CCCCCCCCCCEEEEE | 38.77 | 29967540 | |
| 366 | Ubiquitination | MFNGKVYLLAKKGTD EECCEEEEEEECCCC | 4.14 | 22505724 | |
| 369 | Ubiquitination | GKVYLLAKKGTDVLP CEEEEEEECCCCCCC | 52.27 | 21963094 | |
| 370 | Sumoylation | KVYLLAKKGTDVLPS EEEEEEECCCCCCCH | 62.53 | - | |
| 370 | Sumoylation | KVYLLAKKGTDVLPS EEEEEEECCCCCCCH | 62.53 | - | |
| 370 | Ubiquitination | KVYLLAKKGTDVLPS EEEEEEECCCCCCCH | 62.53 | 22817900 | |
| 384 | Phosphorylation | SQIDQQNSVSPDTPV HHHCCCCCCCCCCCC | 21.45 | 25850435 | |
| 386 | Phosphorylation | IDQQNSVSPDTPVRK HCCCCCCCCCCCCCH | 19.51 | 30576142 | |
| 389 | Phosphorylation | QNSVSPDTPVRKDTL CCCCCCCCCCCHHHH | 27.37 | 21815630 | |
| 393 | Ubiquitination | SPDTPVRKDTLQTVS CCCCCCCHHHHHHHC | 56.13 | 22505724 | |
| 398 | Phosphorylation | VRKDTLQTVSSSPVT CCHHHHHHHCCCCCH | 26.01 | 27174698 | |
| 400 | Phosphorylation | KDTLQTVSSSPVTEI HHHHHHHCCCCCHHH | 28.61 | 25159151 | |
| 401 | Phosphorylation | DTLQTVSSSPVTEIS HHHHHHCCCCCHHHH | 34.03 | 29255136 | |
| 402 | Phosphorylation | TLQTVSSSPVTEISR HHHHHCCCCCHHHHH | 18.84 | 29255136 | |
| 405 | Phosphorylation | TVSSSPVTEISREVV HHCCCCCHHHHHHHH | 30.87 | 29255136 | |
| 408 | Phosphorylation | SSPVTEISREVVNIV CCCCHHHHHHHHHHH | 19.02 | 24732914 | |
| 417 | Ubiquitination | EVVNIVLAKSKSSQM HHHHHHHCCCCCCCC | 11.81 | 22817900 | |
| 418 | Sumoylation | VVNIVLAKSKSSQME HHHHHHCCCCCCCCC | 55.01 | - | |
| 418 | Sumoylation | VVNIVLAKSKSSQME HHHHHHCCCCCCCCC | 55.01 | - | |
| 418 | Ubiquitination | VVNIVLAKSKSSQME HHHHHHCCCCCCCCC | 55.01 | 29967540 | |
| 419 | Ubiquitination | VNIVLAKSKSSQMET HHHHHCCCCCCCCCC | 31.96 | 21963094 | |
| 422 | Phosphorylation | VLAKSKSSQMETKSL HHCCCCCCCCCCCCC | 36.96 | 20860994 | |
| 422 | Ubiquitination | VLAKSKSSQMETKSL HHCCCCCCCCCCCCC | 36.96 | 22817900 | |
| 427 | Sumoylation | KSSQMETKSLSNTQL CCCCCCCCCCCHHHH | 35.77 | - | |
| 427 | Sumoylation | KSSQMETKSLSNTQL CCCCCCCCCCCHHHH | 35.77 | - | |
| 427 | Ubiquitination | KSSQMETKSLSNTQL CCCCCCCCCCCHHHH | 35.77 | 29967540 | |
| 428 | Phosphorylation | SSQMETKSLSNTQLA CCCCCCCCCCHHHHH | 44.44 | 23186163 | |
| 430 | Phosphorylation | QMETKSLSNTQLASM CCCCCCCCHHHHHHH | 44.94 | 23917254 | |
| 432 | Phosphorylation | ETKSLSNTQLASMAN CCCCCCHHHHHHHHH | 22.91 | 23186163 | |
| 436 | Phosphorylation | LSNTQLASMANLRAE CCHHHHHHHHHHHHH | 27.33 | 23917254 | |
| 440 | Ubiquitination | QLASMANLRAEKNKV HHHHHHHHHHHHCCC | 3.89 | 22817900 | |
| 443 | Ubiquitination | SMANLRAEKNKVEKP HHHHHHHHHCCCCCC | 51.21 | 21963094 | |
| 444 | Ubiquitination | MANLRAEKNKVEKPS HHHHHHHHCCCCCCC | 62.17 | 22817900 | |
| 446 | Sumoylation | NLRAEKNKVEKPSPS HHHHHHCCCCCCCCC | 63.94 | 28112733 | |
| 446 | Ubiquitination | NLRAEKNKVEKPSPS HHHHHHCCCCCCCCC | 63.94 | 21963094 | |
| 449 | Ubiquitination | AEKNKVEKPSPSTTN HHHCCCCCCCCCCCC | 54.50 | 22817900 | |
| 451 | Phosphorylation | KNKVEKPSPSTTNPH HCCCCCCCCCCCCCC | 42.42 | 25159151 | |
| 467 | Methylation | NQSSNYLKQSKTLFT CCCCHHHHHCCCCCC | 42.01 | 115972601 | |
| 467 | Ubiquitination | NQSSNYLKQSKTLFT CCCCHHHHHCCCCCC | 42.01 | 22817900 | |
| 470 | Ubiquitination | SNYLKQSKTLFTNPI CHHHHHCCCCCCCCC | 46.91 | 21963094 | |
| 491 | Sumoylation | TGHNAPRKVTAVIYA CCCCCCCEEEEEEEE | 42.76 | - | |
| 491 | Sumoylation | TGHNAPRKVTAVIYA CCCCCCCEEEEEEEE | 42.76 | - | |
| 491 | Ubiquitination | TGHNAPRKVTAVIYA CCCCCCCEEEEEEEE | 42.76 | - | |
| 493 | Phosphorylation | HNAPRKVTAVIYARK CCCCCEEEEEEEECC | 20.45 | - | |
| 500 | Sumoylation | TAVIYARKGSVLQSI EEEEEECCCCHHHHH | 47.57 | - | |
| 500 | Sumoylation | TAVIYARKGSVLQSI EEEEEECCCCHHHHH | 47.57 | - | |
| 500 | Ubiquitination | TAVIYARKGSVLQSI EEEEEECCCCHHHHH | 47.57 | 29967540 | |
| 502 | Phosphorylation | VIYARKGSVLQSIEK EEEECCCCHHHHHHH | 23.77 | 23401153 | |
| 506 | Phosphorylation | RKGSVLQSIEKISSS CCCCHHHHHHHHHCC | 28.67 | 26074081 | |
| 509 | Ubiquitination | SVLQSIEKISSSVDA CHHHHHHHHHCCCCC | 46.33 | 29967540 | |
| 516 | Ubiquitination | KISSSVDATTVTSQQ HHHCCCCCCEECCEE | 11.74 | 21963094 | |
| 532 | Ubiquitination | VFRDQEPKIHNEMAS EECCCCCCCCCHHCC | 56.71 | - | |
| 539 | Phosphorylation | KIHNEMASTSDKGAQ CCCCHHCCCCCCCCC | 27.42 | 21406692 | |
| 540 | Phosphorylation | IHNEMASTSDKGAQG CCCHHCCCCCCCCCC | 31.26 | 21406692 | |
| 541 | Phosphorylation | HNEMASTSDKGAQGR CCHHCCCCCCCCCCC | 34.53 | 21406692 | |
| 543 | Acetylation | EMASTSDKGAQGRND HHCCCCCCCCCCCCC | 56.78 | 25953088 | |
| 543 | Ubiquitination | EMASTSDKGAQGRND HHCCCCCCCCCCCCC | 56.78 | 21906983 | |
| 543 (in isoform 1) | Ubiquitination | - | 56.78 | 21906983 | |
| 554 | Phosphorylation | GRNDKKDSQGRSNKA CCCCCCCCCCCCCCH | 43.33 | 20068231 | |
| 558 | Phosphorylation | KKDSQGRSNKALHLK CCCCCCCCCCHHHCC | 49.89 | 20068231 | |
| 565 | Sumoylation | SNKALHLKSDAEFKK CCCHHHCCCHHHHHH | 35.23 | - | |
| 565 | Sumoylation | SNKALHLKSDAEFKK CCCHHHCCCHHHHHH | 35.23 | - | |
| 565 | Ubiquitination | SNKALHLKSDAEFKK CCCHHHCCCHHHHHH | 35.23 | 29967540 | |
| 578 | Ubiquitination | KKIFGLTKDLRVCLT HHHHCCCCCHHHHHH | 60.86 | 21963094 | |
| 583 | Ubiquitination | LTKDLRVCLTRIPDH CCCCHHHHHHCCCCC | 2.31 | 22817900 | |
| 599 | Phosphorylation | TSGEGFDSFSSLVKS CCCCCHHHHHHHHHC | 25.43 | 25159151 | |
| 601 | Phosphorylation | GEGFDSFSSLVKSGT CCCHHHHHHHHHCCC | 27.06 | 18669648 | |
| 602 | Phosphorylation | EGFDSFSSLVKSGTY CCHHHHHHHHHCCCC | 34.86 | 23186163 | |
| 605 | Sumoylation | DSFSSLVKSGTYKET HHHHHHHHCCCCCCE | 48.76 | 28112733 | |
| 605 | Ubiquitination | DSFSSLVKSGTYKET HHHHHHHHCCCCCCE | 48.76 | 21963094 | |
| 605 (in isoform 1) | Ubiquitination | - | 48.76 | 21906983 | |
| 609 | Phosphorylation | SLVKSGTYKETEFMV HHHHCCCCCCEEEEC | 15.45 | 22817900 | |
| 610 | Ubiquitination | LVKSGTYKETEFMVK HHHCCCCCCEEEECC | 58.98 | 22817900 | |
| 617 | Ubiquitination | KETEFMVKEGERKQQ CCEEEECCCCHHHHH | 48.49 | - | |
| 697 | Phosphorylation | EKRTEMEYYTHEKQE HHHHHHHHHCHHCCC | 16.62 | 27642862 | |
| 698 | Phosphorylation | KRTEMEYYTHEKQEK HHHHHHHHCHHCCCC | 6.57 | 23403867 | |
| 699 | Phosphorylation | RTEMEYYTHEKQEKG HHHHHHHCHHCCCCC | 23.74 | 27642862 | |
| 702 | Sumoylation | MEYYTHEKQEKGTLN HHHHCHHCCCCCCCC | 57.03 | - | |
| 702 | Phosphorylation | MEYYTHEKQEKGTLN HHHHCHHCCCCCCCC | 57.03 | 19081932 | |
| 702 | Sumoylation | MEYYTHEKQEKGTLN HHHHCHHCCCCCCCC | 57.03 | 25218447 | |
| 702 | Ubiquitination | MEYYTHEKQEKGTLN HHHHCHHCCCCCCCC | 57.03 | 29967540 | |
| 705 | Ubiquitination | YTHEKQEKGTLNSNA HCHHCCCCCCCCCCH | 55.49 | - | |
| 707 | Phosphorylation | HEKQEKGTLNSNAAY HHCCCCCCCCCCHHH | 33.56 | 28555341 | |
| 710 | Phosphorylation | QEKGTLNSNAAYEQS CCCCCCCCCHHHHHH | 30.84 | 25627689 | |
| 714 | Phosphorylation | TLNSNAAYEQSHFFN CCCCCHHHHHHHCCC | 16.46 | 25394399 | |
| 722 | Ubiquitination | EQSHFFNKNYTEDIF HHHHCCCCCCCCCCC | 46.29 | 29967540 | |
| 732 | Phosphorylation | TEDIFPVTPPELEET CCCCCCCCCHHHHHH | 33.11 | 17455211 | |
| 739 | Phosphorylation | TPPELEETIRDEKIR CCHHHHHHHCHHHHH | 16.37 | 22199227 | |
| 744 | Ubiquitination | EETIRDEKIRRLKQV HHHHCHHHHHHHHHH | 45.89 | 29967540 | |
| 755 | Ubiquitination | LKQVLREKEAALEEM HHHHHHHHHHHHHHH | 46.34 | 30230243 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LRIF1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LRIF1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LRIF1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RARA_HUMAN | RARA | physical | 17455211 | |
| ESR1_HUMAN | ESR1 | physical | 17455211 | |
| RORA_HUMAN | RORA | physical | 17455211 | |
| PPARG_HUMAN | PPARG | physical | 17455211 | |
| THB_HUMAN | THRB | physical | 17455211 | |
| GCR_HUMAN | NR3C1 | physical | 17455211 | |
| KBTB7_HUMAN | KBTBD7 | physical | 15383276 | |
| GASP2_HUMAN | GPRASP2 | physical | 15383276 | |
| LRIF1_HUMAN | LRIF1 | physical | 15383276 | |
| HAP1_HUMAN | HAP1 | physical | 15383276 | |
| MVD1_HUMAN | MVD | physical | 26496610 | |
| PPM1G_HUMAN | PPM1G | physical | 26496610 | |
| CAF1B_HUMAN | CHAF1B | physical | 26496610 | |
| DCTN3_HUMAN | DCTN3 | physical | 26496610 | |
| DDX42_HUMAN | DDX42 | physical | 26496610 | |
| DJC13_HUMAN | DNAJC13 | physical | 26496610 | |
| SMHD1_HUMAN | SMCHD1 | physical | 26496610 | |
| HAUS5_HUMAN | HAUS5 | physical | 26496610 | |
| SPN90_HUMAN | NCKIPSD | physical | 26496610 | |
| MTHSD_HUMAN | MTHFSD | physical | 26496610 | |
| OSBL5_HUMAN | OSBPL5 | physical | 26496610 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-290, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-402; SER-599 ANDTHR-732, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-402, AND MASSSPECTROMETRY. | |